162 related articles for article (PubMed ID: 35283948)
1. Cytokine profiles in highly active antiretroviral treatment non-adherent, adherent and naive HIV-1 infected patients in Western Kenya.
Musa F; Shaviya N; Mambo F; Abonyo C; Barasa E; Wafula P; Sowayi G; Barasa M; Were T
Afr Health Sci; 2021 Dec; 21(4):1584-1592. PubMed ID: 35283948
[TBL] [Abstract][Full Text] [Related]
2. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects.
Osuji FN; Onyenekwe CC; Ahaneku JE; Ukibe NR
J Biomed Sci; 2018 Dec; 25(1):88. PubMed ID: 30501642
[TBL] [Abstract][Full Text] [Related]
3. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
4. Pro-Inflammatory Cytokine Levels in HIV Infected and Uninfected Pregnant Women with and without Preeclampsia.
Maharaj NR; Phulukdaree A; Nagiah S; Ramkaran P; Tiloke C; Chuturgoon AA
PLoS One; 2017; 12(1):e0170063. PubMed ID: 28095491
[TBL] [Abstract][Full Text] [Related]
5. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
6. T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens.
da Silva TP; Giacoia-Gripp CB; Schmaltz CA; Sant Anna FM; Rolla V; Morgado MG
PLoS One; 2013; 8(6):e66095. PubMed ID: 23840403
[TBL] [Abstract][Full Text] [Related]
7. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
[TBL] [Abstract][Full Text] [Related]
8. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
Keating SM; Golub ET; Nowicki M; Young M; Anastos K; Crystal H; Cohen MH; Zhang J; Greenblatt RM; Desai S; Wu S; Landay AL; Gange SJ; Norris PJ;
AIDS; 2011 Sep; 25(15):1823-32. PubMed ID: 21572306
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
[TBL] [Abstract][Full Text] [Related]
10. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
[TBL] [Abstract][Full Text] [Related]
11. Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
AIDS; 2000 Jan; 14(2):109-16. PubMed ID: 10708280
[TBL] [Abstract][Full Text] [Related]
12. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
[TBL] [Abstract][Full Text] [Related]
14. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
[TBL] [Abstract][Full Text] [Related]
15. The Role of IL-27 and its Receptor in the Pathogenesis of HIV/AIDS and Anti-viral Immune Response.
Zheng YH; Xiao SL; He B; He Y; Zhou HY; Chen Z; Zheng LW; He M; Wang HY; Lin YH; Cao J
Curr HIV Res; 2017; 15(4):279-284. PubMed ID: 28521720
[TBL] [Abstract][Full Text] [Related]
16. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
17. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.
Espíndola MS; Lima LJ; Soares LS; Cacemiro MC; Zambuzi FA; de Souza Gomes M; Amaral LR; Bollela VR; Martins-Filho OA; Frantz FG
PLoS One; 2015; 10(12):e0145261. PubMed ID: 26684789
[TBL] [Abstract][Full Text] [Related]
19. HIV DNA and immune alteration during successful HAART.
Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
[TBL] [Abstract][Full Text] [Related]
20. Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients.
Clerici M; Seminari E; Maggiolo F; Pan A; Migliorino M; Trabattoni D; Castelli F; Suter F; Fusi ML; Minoli L; Carosi G; Maserati R;
AIDS; 2002 Sep; 16(13):1767-73. PubMed ID: 12218388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
